End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.51 MAD | -2.45% | -3.89% | -4.78% |
04-29 | Med Paper S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Med Paper S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2021 | 2022 |
---|---|---|---|---|
Capitalization 1 | 53.98 | 51.65 | 56.14 | 130.4 |
Enterprise Value (EV) 1 | 269.4 | 256.2 | 229.6 | 321.8 |
P/E ratio | - | -8.82 x | 5.92 x | 17.5 x |
Yield | - | - | - | - |
Capitalization / Revenue | 0.69 x | 0.63 x | 0.71 x | 0.97 x |
EV / Revenue | 3.43 x | 3.11 x | 2.91 x | 2.39 x |
EV / EBITDA | - | - | 137,944,019 x | 17,211,685 x |
EV / FCF | - | - | 28,731,292 x | -4,577,702 x |
FCF Yield | - | - | 0% | -0% |
Price to Book | - | -1.35 x | -1.5 x | 6.3 x |
Nbr of stocks (in thousands) | 2,583 | 2,583 | 2,583 | 4,784 |
Reference price 2 | 20.90 | 20.00 | 21.74 | 27.25 |
Announcement Date | 24/04/20 | 24/04/20 | 05/05/23 | 05/05/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2021 | 2022 |
---|---|---|---|---|
Net sales 1 | 78.5 | 82.25 | 78.99 | 134.7 |
EBITDA | - | - | 1.665 | 18.7 |
EBIT 1 | -12.09 | -0.5379 | -2.536 | 13.79 |
Operating Margin | -15.4% | -0.65% | -3.21% | 10.23% |
Earnings before Tax (EBT) 1 | -10.97 | -5.358 | 9.949 | 7.968 |
Net income 1 | -11.38 | -5.857 | 9.484 | 7.429 |
Net margin | -14.5% | -7.12% | 12.01% | 5.51% |
EPS | - | -2.268 | 3.672 | 1.553 |
Free Cash Flow | - | - | 7.993 | -70.3 |
FCF margin | - | - | 10.12% | -52.18% |
FCF Conversion (EBITDA) | - | - | 480.12% | - |
FCF Conversion (Net income) | - | - | 84.27% | - |
Dividend per Share | - | - | - | - |
Announcement Date | 24/04/20 | 24/04/20 | 05/05/23 | 05/05/23 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2021 | 2022 |
---|---|---|---|---|
Net Debt 1 | 215 | 205 | 173 | 191 |
Net Cash position 1 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | 104.2 x | 10.24 x |
Free Cash Flow | - | - | 7.99 | -70.3 |
ROE (net income / shareholders' equity) | 42.6% | 16.6% | -22.5% | -89.2% |
ROA (Net income/ Total Assets) | -2.6% | -0.11% | -0.53% | 2.83% |
Assets 1 | 438.1 | 5,133 | -1,788 | 262.5 |
Book Value Per Share | - | -14.80 | -14.50 | 4.330 |
Cash Flow per Share | - | 0.1500 | 0.3100 | 0.0900 |
Capex | - | - | - | 7.78 |
Capex / Sales | - | - | - | 5.78% |
Announcement Date | 24/04/20 | 24/04/20 | 05/05/23 | 05/05/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-4.78% | 9.29M | |
-1.67% | 19.24B | |
+6.36% | 15.05B | |
+7.38% | 10.56B | |
+1.25% | 6.34B | |
+11.76% | 5.07B | |
+14.18% | 3.98B | |
+17.98% | 3.21B | |
+60.60% | 2.63B | |
+12.70% | 1.77B |
- Stock Market
- Equities
- MDP Stock
- Financials Med Paper S.A.